Remove 2017 Remove BioTech Remove Drug Development Remove Pharmaceuticals
article thumbnail

Patients and Industry: Starting Our New Life Together in 2023

Society for Participatory Medicine

The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. After all of this time and energy expended, it’s only right that patients would be witness to accountability of pharma/biotech to incorporate our collective voice.

BioTech 144
article thumbnail

Genomics Startup Human Longevity’s Valuation Falls 80% from $1.6 Billion down to $310M

Lloyd Price

billion valuation in the last fundraising in early 2017, according to Lagniappe. Existing investors include biotech giant Celgene Corp. , and pharmaceutical entrepreneur Robert Duggan. February 2015: Dr. But key facets of its business didn’t develop as planned, say people familiar with the company.